| Breakdown |
|---|
Income Statement |
| Total Revenue |
| Gross Profit |
| EBITDA |
| Net Income |
Balance Sheet |
| Total Assets |
| Cash, Cash Equivalents and Short-Term Investments |
| Total Debt |
| Total Liabilities |
| Stockholders Equity |
Cash Flow |
| Free Cash Flow |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | ― | ― | ― | ― | ― | ― | |
77 Outperform | $33.21B | 26.19 | 10.10% | 3.15% | 5.74% | 7.12% | |
75 Outperform | $18.19B | 16.17 | 15.56% | 6.14% | -5.21% | -7.45% | |
70 Outperform | $25.62B | 17.32 | 9.03% | 5.03% | -3.16% | 4.70% | |
66 Neutral | $48.29B | 23.53 | 10.09% | 3.48% | 32.48% | -22.94% | |
60 Neutral | $33.18B | 7.35 | -8.37% | 3.77% | 19.67% | -278.51% |